Suppr超能文献

灭活类鼻疽杆菌:体内毒力所需的二硫键氧化还原酶(DsbA)的结构与功能特征

Disarming Burkholderia pseudomallei: structural and functional characterization of a disulfide oxidoreductase (DsbA) required for virulence in vivo.

作者信息

Ireland Philip M, McMahon Róisín M, Marshall Laura E, Halili Maria, Furlong Emily, Tay Stephanie, Martin Jennifer L, Sarkar-Tyson Mitali

机构信息

1 Defence Science and Technology Laboratory , Porton Down, Salisbury, Wiltshire, United Kingdom .

出版信息

Antioxid Redox Signal. 2014 Feb 1;20(4):606-17. doi: 10.1089/ars.2013.5375. Epub 2013 Sep 20.

Abstract

AIMS

The intracellular pathogen Burkholderia pseudomallei causes the disease melioidosis, a major source of morbidity and mortality in southeast Asia and northern Australia. The need to develop novel antimicrobials is compounded by the absence of a licensed vaccine and the bacterium's resistance to multiple antibiotics. In a number of clinically relevant Gram-negative pathogens, DsbA is the primary disulfide oxidoreductase responsible for catalyzing the formation of disulfide bonds in secreted and membrane-associated proteins. In this study, a putative B. pseudomallei dsbA gene was evaluated functionally and structurally and its contribution to infection assessed.

RESULTS

Biochemical studies confirmed the dsbA gene encodes a protein disulfide oxidoreductase. A dsbA deletion strain of B. pseudomallei was attenuated in both macrophages and a BALB/c mouse model of infection and displayed pleiotropic phenotypes that included defects in both secretion and motility. The 1.9 Å resolution crystal structure of BpsDsbA revealed differences from the classic member of this family Escherichia coli DsbA, in particular within the region surrounding the active site disulfide where EcDsbA engages with its partner protein E. coli DsbB, indicating that the interaction of BpsDsbA with its proposed partner BpsDsbB may be distinct from that of EcDsbA-EcDsbB.

INNOVATION

This study has characterized BpsDsbA biochemically and structurally and determined that it is required for virulence of B. pseudomallei.

CONCLUSION

These data establish a critical role for BpsDsbA in B. pseudomallei infection, which in combination with our structural characterization of BpsDsbA will facilitate the future development of rationally designed inhibitors against this drug-resistant organism.

摘要

目的

细胞内病原体伯克霍尔德菌(Burkholderia pseudomallei)可引发类鼻疽病,这是东南亚和澳大利亚北部发病和死亡的主要原因。由于缺乏获批疫苗以及该细菌对多种抗生素具有抗性,开发新型抗菌药物的需求变得更加迫切。在许多临床相关的革兰氏阴性病原体中,DsbA是主要的二硫键氧化还原酶,负责催化分泌蛋白和膜相关蛋白中二硫键的形成。在本研究中,对假定的伯克霍尔德菌dsbA基因进行了功能和结构评估,并评估了其对感染的作用。

结果

生化研究证实dsbA基因编码一种蛋白质二硫键氧化还原酶。伯克霍尔德菌的dsbA缺失菌株在巨噬细胞和BALB/c小鼠感染模型中均表现出毒力减弱,并呈现出多效性表型,包括分泌和运动缺陷。BpsDsbA的1.9 Å分辨率晶体结构显示出与该家族经典成员大肠杆菌DsbA的差异,特别是在活性位点二硫键周围区域,大肠杆菌DsbA与其伴侣蛋白大肠杆菌DsbB在此区域相互作用,这表明BpsDsbA与其假定的伴侣BpsDsbB的相互作用可能与大肠杆菌DsbA - 大肠杆菌DsbB不同。

创新点

本研究对BpsDsbA进行了生化和结构表征,并确定它是伯克霍尔德菌毒力所必需的。

结论

这些数据确定了BpsDsbA在伯克霍尔德菌感染中的关键作用,结合我们对BpsDsbA的结构表征,将有助于未来针对这种耐药生物体合理设计抑制剂的开发。

相似文献

引用本文的文献

8
Anti-Virulence Therapeutic Approaches for .针对……的抗毒力治疗方法
Antibiotics (Basel). 2021 Jan 21;10(2):103. doi: 10.3390/antibiotics10020103.

本文引用的文献

2
Melioidosis.类鼻疽
N Engl J Med. 2012 Sep 13;367(11):1035-44. doi: 10.1056/NEJMra1204699.
7
Introduction to fragment-based drug discovery.基于片段的药物发现简介。
Top Curr Chem. 2012;317:1-32. doi: 10.1007/128_2011_180.
8
Melioidosis: a clinical overview.类鼻疽病:临床概述。
Br Med Bull. 2011;99:125-39. doi: 10.1093/bmb/ldr007. Epub 2011 May 9.
9
iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM.iMOSFLM:一种用于MOSFLM衍射图像处理的新图形界面。
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):271-81. doi: 10.1107/S0907444910048675. Epub 2011 Mar 18.
10
Overview of the CCP4 suite and current developments.CCP4软件包概述及当前进展
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42. doi: 10.1107/S0907444910045749. Epub 2011 Mar 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验